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Abstract
Background: The Elk-1 transcription factor is a member of a group of proteins called ternary complex factors,
which serve as a paradigm for gene regulation in response to extracellular signals. Its deregulation has been linked
to multiple human diseases including the development of tumours. The work herein aims to inform the design of
potential peptidomimetic compounds that can inhibit the formation of the Elk-1 dimer, which is key to Elk-1
stability. We have conducted molecular dynamics simulations of the Elk-1 ETS domain followed by virtual
screening.
Results: We show the ETS dimerisation site undergoes conformational reorganisation at the a1b1 loop. Through
exhaustive screening of di- and tri-peptide libraries against a collection of ETS domain conformations representing
the dynamics of the loop, we identified a series of potential binders for the Elk-1 dimer interface. The di-peptides
showed no particular preference toward the binding site; however, the tri-peptides made specific interactions with
residues: Glu17, Gln18 and Arg49 that are pivotal to the dimer interface.
Conclusions: We have shown molecular dynamics simulations can be combined with virtual peptide screening to
obtain an exhaustive docking protocol that incorporates dynamic fluctuations in a receptor. Based on our findings,
we suggest experimental binding studies to be performed on the 12 SILE ranked tri-peptides as possible
compounds for the design of inhibitors of Elk-1 dimerisation. It would also be reasonable to consider the score-
ranked tri-peptides as a comparative test to establish whether peptide size is a determinant factor of binding to
the ETS domain.
Background
Regulation of gene expression is essential for the devel-
opment of all living organisms through processes such
as cell proliferation, differentiation and morphogenesis.
Key to these processes are mitogen activated protein
kinases (MAPK), which target nuclear transcription fac-
tors, in response to extracellular signals, to elicit the
required genetic response. One such transcription factor
is Elk-1. Elk-1 (Ets-like protein 1) is a member of a
group of proteins called ternary complex factors (TCF),
which are targeted by MAPKs for phosphorylation [1-3]
to regulate the transcription of immediate early genes
(IEG) [4,5]. This event involves the formation of a tern-
ary complex, induced by the cooperative binding of
TCFs with serum response factor (SRF) dimers [6] on
serum response elements found in IEG promoters [7-9].
TCFs are a subfamily of ETS (Etwenty-six) domain pro-
teins. ETS proteins share a ~85 residue DNA-binding
domain (ETS domain) located at the N-terminus of
TCFs, which comprises a ‘winged helix-turn-helix’ motif
[10] that binds to a 10-bp ETS binding site containing a
5’-GGA-3’ core sequence. Since ETS domains are highly
conserved across ETS proteins, ETS binding sites are
differentiated by the cooperation of other transcription
factors [7,11,12] combined with base-specific interaction
with variable bases flanking the central core sequence.
Whilst TCFs naturally form a complex with SRF, they
are also able to bind to DNA containing high-affinity,
autonomous ETS binding motifs independent of a SRF
[6,13]. ETS domain proteins are involved in cellular
development, growth and differentiation [14-16]. Their
deregulation has been linked to multiple human diseases
[17].
* Correspondence: jonathan.hirst@nottingham.ac.uk
1School of Chemistry, University of Nottingham, University Park, Nottingham
NG7 2RD, UK
Full list of author information is available at the end of the article
Hussain et al. Journal of Cheminformatics 2011, 3:49
http://www.jcheminf.com/content/3/1/49
© 2011 Hussain et al; licensee Chemistry Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
The current X-ray crystal structure of the Elk-1 ETS
domain is that of a dimer, with each unit bound to an
autonomous 13-bp DNA double helix (PDB code
1DUX) [18] composed of a high affinity ETS binding
site motif. Like other ETS domain proteins, the struc-
ture reveals three a-helices packed against four anti-par-
allel b-strands, giving an abbaabb secondary structure
(Figure 1). The a3 helix forms the recognition helix,
which slots into the major groove of the DNA target
with a GGA core (Figure 2a). The dimer interface
involves the carboxy-end of a1 and the a1b1 loop (Fig-
ure 2b). Contrary to the aforementioned structure,
unequivocal experimental evidence has indicated that
ETS dimers exist only in solution, [19,20] whilst mono-
mers occur predominantly in the nucleus, where they
target DNA [21,22]. To date, the structure of an
unbound ETS domain is yet to be reported. However,
Saven et al. [23] performed molecular dynamics (MD)
simulations of a single Elk-1 ETS domain taken from
the dimeric structure. They discerned regions within the
simulated monomeric structure which showed large
structural deviation with respect to the structure of the
domain in the dimeric conformation. These regions
include residues at the a1b1 loop involved in the ETS
dimer interface and residues at the a2a3 loop involved
in protein-DNA contacts.
Thus far, work on characterising the mechanism for
protein-DNA recognition in TCFs has been abundant
[18,23-27]. However, there has been little on under-
standing the basis of Elk-1 dimerisation for transcrip-
tional activity. Shaw and colleagues [21] have identified
a region of the Elk-1 ETS domain encompassing the
a1b1 loop which distinctly contributes to Elk-1 stability
in the cytoplasm by directing Elk-1 dimer formation.
Also, dimerisation in the cytoplasm appears to prevent
rapid degradation and plays a role in translocation of
the protein to the nucleus and its subsequent accumula-
tion therein.
In the current work, we identify a series of peptides
that can serve as leads for the design of potential peptido-
mimetic inhibitors of Elk-1 dimerisation. Using a dock-
ing-based approach, we screened entire libraries of all
possible di- and tri-peptides against the Elk-1 ETS
domain, targeting the stability region of the domain iden-
tified by Shaw et al [21]. Given the findings of Saven et
al., [23] it was essential to consider possible structural
deviations or fluctuations in the a1b1 loop region that
may affect binding of such inhibitors. Therefore, we per-
formed MD simulations for an Elk-1 ETS monomer, to
generate an ensemble of monomeric ETS conformations
to use as docking targets. Herein, we show that tri-pep-
tides appear to be good candidates for the design of inhi-
bitors/binders of the Elk-1 dimer interface, based on size
and binding specificity; di-peptides, on the other hand,
appeared to behave as generic protein surface binders.
We have also identified a set of tri-peptides, which may
bind competitively to the ETS dimer interface.
Computational Methods
Molecular Dynamics Simulations
All stages of the MD simulations were carried out using
CHARMM version 34b1 [28,29] with the all-atom
Figure 1 ETS domain secondary structure. Amino acid sequence of the Elk-1 ETS domain, showing the locations of a-helices and b-strands.
Figure 2 ETS domain DNA and dimer complexes. (a) An Elk-1 ETS domain bound to its DNA recognition sequence. a-helices are in purple
and b-strands in yellow. (b) An Elk-1 ETS domain dimer complex, showing the a1b1 loops providing the interface. The images were generated
using VMD [63] and PovRay (http://www.povray.org/), using coordinates taken from the 1DUX crystal structure [18].
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CHARMM22 force field [30] and CMAP extensions
[31-33]. Our initial structure of a representative ETS
domain monomer was chain C from the 1DUX crystal
structure [18]. For residues with alternative positions,
the pose with the highest occupancy was retained.
Hydrogen atoms were assigned using the HBUILD mod-
ule [34]. The system underwent three rounds of energy
minimisation using the conjugated gradient method to
remove any unphysical contacts until the system had
converged. During the minimization all non-hydrogen
atoms were harmonically restrained with a force con-
stant of 30 kcal mol-1 Å-1, which was reduced by 10
kcal mol-1 Å-1 at each successive round. The system was
solvated in a cubic solvation box (62.2 Å × 62.2 Å ×
62.2 Å), containing 7460 TIP3P water molecules, [35]
using periodic boundary conditions. The fully solvated
system was minimised using the conjugated gradient
method. First, the protein was fixed to allow the water
molecules to minimise and then harmonically restrained
with a force constant of 30 kcal mol-1 Å-1. A switched
cut-off was used at an atom-pair distance of 10 Å for
calculations of non-bonded interactions with a 2.0 Å
switching region. The Particle Mesh Ewald algorithm
was used for calculating long-range electrostatic interac-
tions [36]. The system was gradually heated from 0 K to
300 K and allowed to equilibrate for 100 ps. The
SHAKE algorithm [37] was applied to constrain all
hydrogen-heavy atom bonds to remove the need to sam-
ple the high frequency vibrations. Simulations were per-
formed with a 1 fs timestep with the Leapfrog
integrator. Following equilibration, the simulation con-
tinued for a further 4 ns in the isobaric-isothermal (con-
stant pressure and temperature, NPT) ensemble for the
production run. During this phase, structural coordi-
nates of the system were taken at 0.1 ps intervals to
build a trajectory of the system dynamics. Time-depen-
dent properties were calculated from the production tra-
jectory. In preparation for this, the Ca atoms from each
frame of the trajectory were aligned using least-squares
fitting to the coordinates of the starting conformation.
The root mean square deviation (RMSD) from the initial
conformation and radius of gyration were calculated to
survey any structural fluctuations over the time-series.
To evaluate local structural deviations between the
simulated ETS monomer conformations and the initial
dimmer conformation, a residue-specific RMSD of
main-chain atoms (N, Ca, C, O) was calculated, aver-
aged for the entire conformational ensemble. To com-
plement this, we examined the changes in the backbone
dihedral angles for structural fluctuations at residues
around the a1b1 loop region (16-23).
Several snapshots were extracted from the trajectory
to represent the various conformations for an Elk-1 ETS
monomer. This was done by clustering the trajectory
using backbone dihedral angles for residues 20-22 and
selecting the conformation closest to the centre of each
cluster as a representative conformation. The threshold
defining the size of each cluster was the average of the
standard deviation for the six chosen angles, over the
time-series.
Automated Peptide Docking
Libraries of all possible di-and tri-peptide were built
using all 20 standard, genetically encoded amino acids
(400 di-peptides and 8,000 tri-peptides). The first step
was to generate a SMILES string [38] from the raw pep-
tide sequences, using ChemAxon’s MolConverter pro-
gram [39]. For each peptide, tautomers at physiological
pH (7.4) were produced using ChemAxon’s Calculator
Plugins [40]. Any unreasonable peptide structures were
removed from each library, including any structures
with protonated carbonyl groups, de-protonated amines,
structures without formally charged termini, and struc-
tures with anionic amides. Each peptide library was
docked to the ETS monomer conformations obtained
from the clustering. The dockings were carried out
using OpenEye’s docking program FRED, [41] a rigid
docking algorithm, which requires a pre-computed con-
former ensemble for screening the conformational space
of the ligands. The conformer ensembles were created
using Omega version 2.3.2 (OpenEye Scientific Software)
[42]. A maximum of 500 low energy conformers were
constructed for each peptide, in vacuo, using the
MMFF94s force field [43,44]. The Coulombic and
attractive part of the van der Waals terms were
excluded from the force field, to reduce the effects of
strong intermolecular interactions (e.g. hydrogen bonds)
that can result in folded (peptide) conformations. Con-
formers with an energy difference greater than 25 kcal
mol-1 from the lowest energy conformer were rejected
and conformers in the final ensemble were required to
have a heavy atom RMSD greater than the duplicate
removal threshold (0.4 Å). These settings were in line
with the “high quality screening” settings of Kirchmair
et al [45]. All remaining parameters were the default
values.
The docking site for each receptor was delineated by a
grid box encasing residues at the Elk-1 dimer interface
site. A protein contact constraint, which all successful
dockings were require to satisfy, was defined on Leu45,
which is a key pharmacophoric contact for the dimer
interface. The di- and tri-peptide libraries (with confor-
mers) were separately docked, using FRED version 2.2.5,
to each of the Elk-1 ETS domain conformations. Each
multi-conformer peptide-ligand was exhaustively docked
to a receptor using default step-sizes and the Chem-
Gauss2 scoring function (a propriety function of Open-
Eye) [41].
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ChemGauss2 is a chemically aware shape-fitting scor-
ing function, which uses Gaussian functions to describe
the shape and chemistry of molecules. The best scoring
poses for each compound were optimised in their
docked state by half a rotation and translation step in
each direction using the OEChemScore scoring function.
OEChemscore is an OpenEye variant of the Chemscore
[46] scoring function, but lacks a component for an
entropy penalty upon complex formation.
On completion of the docking simulations, the single
highest-scoring tautomeric state of each peptide was
taken to give 400 unique di-peptides and 8,000 unique
tri-peptides. Results from both libraries were analysed
similarly but separately. The peptides were initially
ranked by docking score, where rank 1 corresponded to
the highest scoring peptide. Due to the variability in the
size of peptides in both libraries, where size is a simple
heavy atom count (HAC), and a systematic bias in the
scoring functions (including OEChemscore), [47,48] we
employed a simple size-independent metric to rank pep-
tides and select the best binders. We used the size-inde-
pendent ligand efficiency (SILE) metric [49]:
SILE =
affinity
HAC1−x
(1)
where affinity can be any binding measurement, in our
case the docking score; x is derived by fitting the maxi-
mal ligand efficiency (LEmax) values from all 12 docking
screens against HAC, to a logarithmic function of the
form:
ln(LEmax) = k− x ln(HAC) (2)
Docking data from the di- and tri-peptide sets were
fitted and examined separately.
Docked complexes between the highest-ranked pep-
tides and the 12 protein conformations were analysed
using HBPLUS, using default parameters [50]. Only
hydrogen bonds between protein and peptide ligands
were considered. The number of ETS residues partici-
pating in interactions with the top SILE-ranked peptide
in each complex was counted. This count was also dis-
sected into the number of specific contacts made, where
specificity is defined as interactions between peptide
side-chains and ETS residues.
Results and Discussion
Analysis of Elk-1 dimer interface
In order to aid the identification of possible peptide bin-
ders for the Elk-1 dimer interface, it was important to
identify structural features contributing the dimerisation.
Interactions between two Elk-1 ETS domains were cal-
culated using the LIGPLOT program [51]. The mini-
mum and maximum interatomic bond distances for
non-bonded contacts were 2.90 Å and 3.90 Å, respec-
tively, and for hydrogen bonds: 2.70 Å and 3.35 Å. The
LIGPLOT diagram for chains C and F from the X-ray
crystal structure of the ETS dimer (Figure 3) reveals a
homodimeric interaction between the two ETS domains.
Key to the interface were residues 17, 18 and 49, where
Gln18 and Arg49 of one domain donate three hydrogen
bonds to Glu17 of the partnering domain. Accompany-
ing these hydrogen bond interactions, several residues
make large steric contributions to the interface; these
are listed in Table 1 together with a percentage accessi-
ble surface area of the interface, calculated using NAC-
CESS [52]. The schematic depicting the secondary
structure of the ETS domain in Figure 1 shows the rela-
tive positions of these residues in the domain.
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Figure 3 ETS domain dimer interface. LIGPLOT representation of
intermolecular interactions between two Elk-1 ETS domains
according to the X-ray crystal structure (1DUX) of the dimer
complex. Non-bonded interactions are indicated by spokes and
hydrogen bonds by dashed green lines, with lengths given in Å.
Residues from chain C are shown with purple bonds and chain F in
orange.
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MD simulations of an Elk-1 ETS domain
Over the course of the MD simulation, the radius of
gyration (RoG) and the RMSD of the backbone atoms
relative to the minimised (initial) structure of each
frame in the trajectory remained stable. The mean
values for the RMSD and the RoG were 1.64 ± 0.24 Å
and 12.17 ± 0.08 Å, respectively. The latter was, in fact,
identical to the RoG of the initial structure. This indi-
cated that the overall shape and size (packing) of both
the monomeric and dimeric conformation of the Elk-1
ETS domain is conserved. To focus on localised struc-
tural deviations, we calculated the time-averaged RMSD
for each residue, with respect to the main-chain atoms
of the initial conformation. This revealed substantial
structural deviations for residues 20-22 compared to the
dimeric conformation (Figure 4). These residues are
situated at the centre of the a1b1 loop, which was iden-
tified by Shaw et al. [21] as the region accountable for
Elk-1 stability. We also measured the backbone dihedral
angles for residues in the loop across the entire trajec-
tory. Residues 16 to 19 and residue 23 showed dihedral
angle fluctuations within range of typical thermal fluc-
tuations for proteins, with an average standard deviation
about the mean of ±19° across the trajectory for the 10
angles; fluctuations of the backbone dihedrals for
residues 21 and 22 were considerably larger, with the
lowest standard deviation value of ±59° and the highest
of ±88°. The high fluctuation of residues 21 and 22 are
consistent with the high RMSD values seen in Figure 4.
Since the structure fluctuates in the region coinciding
with the a1b1 loop, which was our proposed docking
binding site, it would have been unreasonable to dock
to the single domain conformation taken from the crys-
tal structure of the dimer, or to dock to the averaged
structure of the MD trajectory. Instead, we clustered the
trajectory, based on the backbone dihedral angles of
residues 20-22, to extract several conformations repre-
sentative of an Elk-1 ETS domain monomer. Using a
clustering threshold of 49.2°, which was the average of
the standard deviations of the six angles, 12 clusters
were obtained. From each cluster, a single conformation
was taken (Table 2) and used for the docking study. (see
Additional file 1 for an alignment of the minimised
structure and the 12 conformations).
Peptide Docking
Peptide screening
Libraries of all possible di- and tri-peptides, together
with possible tautomers of each peptide were con-
structed. The final libraries (including protonation and
tautomeric states) were made up of 1,128 di-peptides
and 33,367 tri-peptides. The two peptide libraries were
individually screened against the 12 monomer confor-
mations of the Elk-1 ETS domain. Each multi-conformer
peptide-ligand was exhaustively docked to the receptors,
i.e., all rigid-body translations and rotations of a confor-
mer were enumerated within the docking site, centred
on residues for the Elk-1 dimer interface. Although with
different affinities, all peptides bound to the docking site
with favourable scores.
The docked peptide-ligands for each library were
ranked according to docking score, retaining only the
highest scoring tautomer of each peptide. Using this
simple ranking scheme, particularly for the di-peptides,
Table 1 Residue contribution to the dimer interface
accessible surface area (ASA), calculated using NACCESS
[52]
Residue % contribution to interface ASA
Gln13 4.6
Arg16 17.6
Glu17 22.0
Gln18 8.8
Gly19 2.6
Asn20 5.3
Leu45 8.5
Leu48 8.4
Arg49 14.4
Figure 4 Residue specific ETS monomer fluctuations. Time-averaged RMSD for the main-chain atoms of each residue over 4 ns of simulation
of an Elk-1 ETS domain. The bars signify fluctuations about the mean and correspond to one standard deviation.
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peptide-ligands with a larger heavy atom count (HAC)
were ranked higher than those with a smaller one.
Although this effect is apparent in experimental ligand
binding data, [53] unfortunately it is unduly amplified in
computational docking studies. The problem stems from
the additive nature of scoring functions. The scoring
function tends to favour larger ligands, as they contri-
bute towards a greater number of intermolecular inter-
actions with the target. This phenomenon is inherent to
several docking scoring functions, including OEChem-
score, which lack other terms in the function, such as a
desolvation penalty term, that can counter-balance the
favoured interaction terms. For our peptide ligands, the
effect is seen in Figures 5a and 5b for the highest scor-
ing di- and tri-peptides, respectively, taken at each HAC
from the 12 docking screens.
Because the bias towards larger ligands is counter to
the rules for drug bioavailability, [54] a simple metric,
called ligand efficiency has been developed to assess the
binding of a compound, with respect to the number of
atoms, and its potential for lead optimisation [53,55].
Ligand efficiency (LE) is the binding affinity (potency)
divided by a measure of the size of a ligand, often the
HAC, as defined by Kuntz et al [53]. Compounds that
can provide the desired binding affinity with fewer
atoms are considered efficient. However, in large screen-
ing studies of ligands spanning a wide range of molecu-
lar sizes, ligand efficiency is non-linearly related to
HAC, and appears to fall as size increases [56,57]. This
trend can be illustrated by plotting the LE versus HAC
(Figure 6), for the peptides used in Figure 5. The trend
may be related to the increased complexity of larger
compounds. More complex compounds can bind a tar-
get with a less than optimal geometry, due to binding
constraints and structural compromises [58]. They also
offer a smaller surface area per atom to make favourable
interactions compared to smaller, less complex com-
pounds [56]. LE over-corrects for the size dependence
in docking scores. Therefore, a size-normalised effi-
ciency scale was needed. We used the size-independent
ligand efficiency (SILE) [49] scale to rank peptides in
the docked libraries. In order to apply a SILE metric for
our data, a value for x, for Equation (1), was obtained
by fitting the maximal LE (LEmax) values taken from
Figure 6 to the function in Equation (2) (see Additional
file 1). LEmax is the highest LE value at each HAC. The
x values for di- and tri-peptides were 0.649 and 0.665,
respectively, which were close to the generic value of 0.7
suggested by Nissink [49].
By mapping the two sequence positions for ranked di-
peptides on to a 20 × 20 matrix, where each square is
graded according to the associated rank, we can see the
difference in size-dependence between score- and SILE-
ranked results (Figures 7a and 7b). Score-ranked
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Figure 5 Highest scoring peptides by size. Highest scoring (a) di-peptides and (b) tri-peptides taken at each HAC from all 12 docking screens.
Docking scores have been plotted as non-negative values for convenience.
Table 2 ETS monomer conformations obtained by
clustering the MD trajectory on the backbone dihedral
angles of residues 20-22 (cluster threshold = 49.2°)
Cluster % of MD trajectory
ETS1 11.5
ETS2 4.0
ETS3 5.9
ETS4 8.9
ETS5 4.8
ETS6 16.4
ETS7 7.1
ETS8 1.4
ETS9 4.1
ETS10 4.6
ETS11 21.2
ETS12 10.1
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matrices clearly show peptides consisting of heavier
amino acid residues such as tryptophan and tyrosine
ranked higher, whilst those of smaller residues such as
alanine and glycine ranked lower. The SILE-ranked
matrices reduce this bias (Figure 7b). Similarly, plots of
the distribution of LE and SILE values for the di- and
tri-peptide dockings as a function of HAC reveal a
reduced size-dependency for SILE values compared to
LE values (compare Figure 8b with 8a and 8d with 8c).
However, the SILE values for di-peptides maintain some
size dependence (Figure 8b) compared to the tri-pep-
tides (Figure 8d). It may be that the binding site readily
accommodates the di-peptides, due to their smaller size
and low structural complexity, and thus the size bias
remains dominant. Therefore, di-peptides with a lower
HAC bind and fit the binding site more completely,
where a greater number of atoms participate equally in
protein-peptide interactions compared to tri-peptides
and di-peptides with a higher HAC. A similar result was
observed in a peptide docking study to the Fv fragment
of a monoclonal IgM cryoglobulin [59]. In that study,
docking results were skewed towards di-peptides com-
posed of larger residues. It was suggested that the di-
peptides were too small to discriminate between differ-
ent binding cavities, which is consistent to the hypoth-
esis of ‘a small ball in a large hole’. Thus, the size-
independent metric is less effective for compounds of
lower complexity. This also suggests that di-peptides are
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Figure 6 Peptide binding efficiencies by size. Highest ligand efficiency values for (a) di-peptides and (b) tri-peptides taken at each HAC from
all 12 docking screens.
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Figure 7 Docked di-peptide ranking maps. 2D-maps representing the peptide rank by (a) docking score and (b) SILE values according to the
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fairly promiscuous protein surface binders and may not
offer a specific binding preference for the dimer inter-
face site had the docking site definition been larger.
Tables 3 and 4 list the highest score- and SILE-ranked
di- and tri-peptides, respectively. These tables again
reveal the preference for peptides consisting of large
aromatic residues for the score-ranked results, particu-
larly for the di-peptides. In addition to the factors dis-
cussed above, it is possible such residues may behave as
anchors to aid the binding of the complete peptides.
However, given that a minority (38%) of residues in the
dimer interface are non-polar, it is perhaps unlikely that
these hydrophobic residues, especially tryptophan and
tyrosine, would show particular affinity for the binding
site in experimental assays.
Structural analysis of docked complexes
Interactions between the top SILE-ranked peptide-pro-
tein complexes were calculated for each Elk-1 ETS
domain conformation. Given the systematic bias in the
score-ranked results, they were not considered for inter-
action analysis. Overall, both sets of peptides interact
with residues in the dimer interface, namely the regions
at sequence positions 10-20 and 40-50. To investigate
the specificity of binding, the number of ETS domain
Figure 8 Peptide efficiency distribution. Distribution of LE ((a) and (c)) and SILE ((b) and (d)) values for docked di- and tri-peptides as a
function of the number of heavy atoms. (a) LE and (b) SILE values for di-peptides; (c) LE and (d) SILE values for tri-peptides.
Table 3 Highest score- and SILE-ranked di-peptides
Score-ranked SILE-ranked
Protein conformation Sequence Heavy atom count Sequence Heavy atom count
ETS1 WY 27 YQ 22
ETS2 GK 14 GD 13
ETS3 WY 27 YG 17
ETS4 WY 27 WY 27
ETS5 TY 20 AY 18
ETS6 DW 23 YA 18
ETS7 YW 27 QY 22
ETS8 WY 27 YG 17
ETS9 YY 25 VY 20
ETS10 KE 19 KE 19
ETS11 EW 24 SY 19
ETS12 YW 27 YW 27
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residues hydrogen bonded with a peptide were counted
for each of the docked complexes. On average, di-pep-
tide ligands interacted with fewer ETS domain residues
compared to tri-peptides (column 2, Tables 5 and 6),
although some of these interactions did include those
made to ETS domain residues Glu17, Gln18 and Arg49,
which were identified as key hydrogen-bond contacts at
the dimer interface (see Figure 3). In addition, the high-
est SILE-ranked tri-peptides make more specific con-
tacts to the protein compared to the highest-ranked di-
peptides (column 3, Tables 5 and 6). Here, we measure
specificity as interactions between peptide side-chains
and ETS residues. Figure 9 shows an “Interaction finger-
print” of the hydrogen bonds between the highest SILE-
ranked peptide and the corresponding ETS conforma-
tions. The Elk-1 ETS domain dimer fingerprint is given
at the top of the figure as a reference.
Perhaps naively we may have expected a peptide cor-
responding to a contiguous sequence of residues
involved in the Elk-1 dimer interface would have been
ranked high in the docking simulation, but this was not
the case. The most obvious such peptides were, the tri-
peptide Arg-Glu-Gln, which corresponds to residues 16-
18 in the ETS domain, and the di-peptide Glu-Gln cor-
responding to residues 17-18 (as seen in Figure 3). The
best SILE-ranked Glu-Gln di-peptide was ranked 52 out
of 400 in complex with ETS7 and had an average rank-
ing of 133 for all 12 docked complexes. Whilst the best
SILE-ranked Arg-Glu-Gln tri-peptide was ranked 1423
out of 8000 in complex with ETS8 and an average rank-
ing of 3729 (Table 7). This is largely because these pep-
tides, although capable of providing some of the
hydrogen bond interactions found at the dimer inter-
face, are unable to mimic the interactions of other resi-
dues involved in dimer interface (see Table 1 and Figure
3), particularly van der Waals contacts. This has been
recognised in other efforts to discover small molecules
that disrupt protein-protein interactions [60]. For this
reason, the binding of the two aforementioned peptides
may be weaker than the higher ranked peptides, which
satisfy more of the pharmacophoric constraints of the
dimer.
Table 4 Highest score- and SILE-ranked tri-peptides
Score-ranked SILE-ranked
Protein conformation Sequence Heavy atom count Sequence Heavy atom count
ETS1 IYW 35 TKT 24
ETS2 GYY 29 GGD 17
ETS3 YKE 31 YKE 31
ETS4 KWR 35 SYG 23
ETS5 HAY 28 TTG 19
ETS6 KEY 31 KEY 31
ETS7 RYW 38 SFG 22
ETS8 LWY 35 SYA 24
ETS9 EHW 34 TDY 28
ETS10 WYV 34 KSD 24
ETS11 DYW 35 YSY 31
ETS12 KEW 33 TYF 31
Table 5 Number of ETS residues participating in hydrogen bond interactions with highest SILE-ranked di-peptides
Di-peptide complex ETS residues in peptide-protein hydrogen bonds ETS residues in peptide specific hydrogen bonds
ETS1/YQ 3 3
ETS2/GD 5 1
ETS3/YG 2 0
ETS4/WY 4 2
ETS5/AY 3 2
ETS6/YA 4 3
ETS7/QY 5 2
ETS8/YG 3 2
ETS9/VY 2 0
ETS10/KE 4 3
ETS11/SY 5 3
ETS12/YW 4 3
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Conclusions
It is well-established that TCFs, such as Elk-1, play a
critical role in transcriptional activation in response to
extracellular signals and a consequent role in the growth
and development of cells. Using MD simulations we
have identified possible conformations for an Elk-1 ETS
domain monomer and observed a structural variation
from the dimeric form at the a1b1 loop, where two Elk-
1 proteins dimerise. Against these monomeric confor-
mations we screened all possible di- and tri-peptides
and have identified several peptides with potential to
mimic and possibly inhibit Elk-1 dimerisation. The size
and binding specificity of the tri-peptides make them
ideal candidates for the design of peptidomimetics of
the Elk-1 dimer interface. The di-peptides, on the other
hand, appear to be a generic set of protein surface bin-
ders and are unlikely to produce experimental binding
affinity for the ETS dimer interface site that would cor-
relate with the docking data. The notion of using tri-
peptides as potential candidates for peptidomimetic
design has also been supported in a recent review by
Ung and Winkler [61].
Since docking scoring functions are based on a num-
ber of simplifications and assumptions, their predictions
for binding free energies for a protein-ligand complex
are not quantitative. This also makes it very difficult to
discriminate between strong/weak binders and non-bin-
ders, particularly for a relatively at and exposed binding
site, as investigated here. Although this is a major lim-
itation in a docking protocol, the exhaustive search algo-
rithm of docking programs has been successful in
predicting correct binding geometries of known hits
[48]. As with all docking protocols, true validation can
only be achieved through experimental binding mea-
surements correlating with the docking results. For an
experimental binding study, it would be reasonable to
test the binding affinity of the top SILE-ranked tri-pep-
tides listed in Table 4. The score-ranked tri-peptides
Table 6 Number of ETS residues participating in hydrogen bond interactions with highest SILE-ranked tri-peptides
Tri-peptide complex ETS residues in peptide-protein hydrogen bonds ETS residues in peptide specific hydrogen bonds
ETS1/TKT 5 4
ETS2/GGD 6 1
ETS3/YKE 6 5
ETS4/SYG 4 3
ETS5/TTG 5 3
ETS6/KEY 6 4
ETS7/SFG 2 2
ETS8/SYA 3 3
ETS9/TDY 4 2
ETS10/KSD 5 4
ETS11/YSY 5 3
ETS12/TYF 4 3
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Figure 9 Peptide hydrogen bond fingerprints. Hydrogen bond “Interaction fingerprints” for docked complexes between Elk-1 ETS domain
conformations and highest SILE-ranked (a) di- and (b) tri-peptides. Specific contacts, as described in the main text, are given in red and peptide
main-chain contacts in blue.
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may also be worth considering as a comparative test to
establish whether size of the peptide is a determinant
factor of binding to the ETS domain or if it is, indeed,
just an artefact of docking. Binding data for the Arg-
Glu-Gln peptide may also be useful in explaining the
poor predicted binding by the docking simulations.
It is quite clear that complex formation of a protein
and ligand is a dynamic mechanism. Here we have
shown a combination of MD and docking simulations
can be used to provide an understanding of the effects
on ligand binding to a dynamic representation of the
receptor, which a single configuration crystal structure
would fail to reveal. Thus, computer simulations on pro-
tein-ligand complexes can enhance crystal structure data
in this respect. We plan to extend the current work by
performing all-atom MD simulations of selected pep-
tides complexed with an Elk-1 ETS domain to assess the
stability of the complexes, whilst incorporating any
induced fitting of the peptides and obtain accurate bind-
ing data for use in designing future docking studies of
optimised peptides. We also plan to apply free energy
perturbation methods [62] to a set of the best peptides
to calculate relative binding free energy of alchemic
transformations of the peptides in complex with the
Elk-1 ETS domain. This may also go as far as identifying
tetra-peptides with potentially superior binding affinities
compared to the tri-peptides we have considered here.
Additional material
Additional file 1: Superposition of ETS target structures and
derivation of maximal ligand efficiency. Document contains: 1) figures
showing alignment of the 12 ETS target structures with the minimised
structure and 2) plots showing the maximal ligand efficiency values for
the docked di- and tri-peptides.
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